Although our findings are derived in a cross-sectional survey, the finding of TL as a prognostic biological aging biomarker for C-peptide, independent of obesity and CRP, may increase our knowledge to assess disease risk and may also increase our understanding of the underlying pathways and mechanisms for the association of biological aging with a wide range of metabolic disorders. Here, CRP is linked to Other metabolic disease.